Category Biology/Biotechnology

Researchers are developing a ground-breaking method that uses biomarkers to detect sepsis 2 to 3 days before the first clinical symptoms appear. This can significantly increase the chances of survival in cases of blood poisoning by bacteria or fungi.

Whether activating or silencing genes, breaking down defective cells or building new tissue, our body is constantly working to repair itself, even in cases of illness. To fight a disease, our body sends out signals, often long before we ourselves notice the disease...

Abnormal levels of stress hormones such as adrenaline and cortisol are linked to a variety of mental health disorders, including depression and posttraumatic stress disorder (PTSD). MIT researchers have now devised a way to remotely control the release of these hormones from the adrenal gland, using magnetic nanoparticles.

This approach could help scientists to learn more about how hormone release influences mental health, and could eventually offer a new way to treat hormone-linked disorders, the researchers say...

To address plastic pollution plaguing the world’s seas and waterways, Cornell University chemists have developed a new polymer that can degrade by ultraviolet radiation, according to research published in the Journal of the American Chemical Society.

“We have created a new plastic that has the mechanical properties required by commercial fishing gear. If it eventually gets lost in the aquatic environment, this material can degrade on a realistic time scale,” said lead researcher Bryce Lipinski, a doctoral candidate in the laboratory of Geoff Coates, professor of chemistry and chemical biology at Cornell University. “This material could reduce persistent plastic accumulation in the environment.”

Commercial fishing contributes to about half of all floating plastic waste that ends ...

Drug resistance is a major obstacle in cancer treatment – leading to relapse for many patients. In a new study, published online April 20, 2020, in Nature Cell Biology, researchers from the Stowers Institute for Medical Research, Children’s Mercy Kansas City, and The University of Kansas Cancer Center report on a promising new strategy to overcome drug resistance in leukemia, using targeted doses of the widely-used chemotherapy drug doxorubicin.

The study’s researchers found that low doses of the anthracycline antibiotic doxorubicin inhibit the interaction between two molecular pathways that work closely together to promote tumor ...